WU ZHANG
机构: University of Southern California/Norris Cancer Center
每年引用次数
引用次数
引用: 13,135
H-指数: 56
I10-指数 : 152
出版物: 380
TWIST1 Polymorphisms Predict Survival in Patients with Metastatic Colorectal Cancer Receiving First-Line Bevacizumab plus Oxaliplatin-Based Chemotherapy
Satoshi Matsusaka , Wu Zhang , Shu Cao , Diana L. Hanna
Molecular Cancer Therapeutics 15 ( 6) 1405 -1411
6
2016
Clinical significance of TLR1 I602S polymorphism for patients with metastatic colorectal cancer treated with FOLFIRI plus bevacizumab
Satoshi Okazaki , Fotios Loupakis , Sebastian Stintzing , Shu Cao
Molecular Cancer Therapeutics 15 ( 7) 1740 -1745
6
2016
Expression of genes involved in vascular morphogenesis and maturation predicts efficacy of bevacizumab-based chemotherapy in patients undergoing liver resection
Stefan Stremitzer , Wu Zhang , Dongyun Yang , Yan Ning
Molecular Cancer Therapeutics 15 ( 11) 2814 -2821
4
2016
Tumor Sidedness and Enriched Gene Groups for Efficacy of First-line Cetuximab Treatment in Metastatic Colorectal Cancer
Yu Sunakawa , Kaoru Mogushi , Heinz-Josef Lenz , Wu Zhang
Molecular Cancer Therapeutics 17 ( 12) 2788 -2795
1
2018
Molecular Characterization of Appendiceal Goblet Cell Carcinoid
Hiroyuki Arai , Yasmine Baca , Francesca Battaglin , Natsuko Kawanishi
Molecular Cancer Therapeutics 19 ( 12) 2634 -2640
1
2020
Tandem repeat variation near the HIC1 (hypermethylated in cancer 1) promoter predicts outcome of oxaliplatin‐based chemotherapy in patients with metastatic colorectal cancer
Satoshi Okazaki , Marta Schirripa , Fotios Loupakis , Shu Cao
Cancer 123 ( 22) 4506 -4514
11
2017
Genetic variations in angiopoietin and pericyte pathways and clinical outcome in patients with resected colorectal liver metastases
Stefan Stremitzer , Wu Zhang , Dongyun Yang , Yan Ning
Cancer 121 ( 11) 1898 -1905
5
2015
FCGR2A and FCGR3A Polymorphisms Associated With Clinical Outcome of Epidermal Growth Factor Receptor–Expressing Metastatic Colorectal Cancer Patients Treated With Single-Agent Cetuximab
Wu Zhang , Michael Gordon , Anne M. Schultheis , Dong Yun Yang
Journal of Clinical Oncology 25 ( 24) 3712 -3718
405
2007
Pharmacogenomics of 5-Fluorouracil/Oxaliplatin in Colorectal Cancer
Michael Gordon , Wu Zhang , Heinz-Josef Lenz
Current Pharmacogenomics 4 ( 4) 277 -283
2006
Molecular determinants of irinotecan efficacy.
Daniel Vallböhmer , Syma Iqbal , Dong Yun Yang , Katrin E. Rhodes
International Journal of Cancer 119 ( 10) 2435 -2442
61
2006
Colorectal cancer: epigenetic alterations and their clinical implications.
Alberto Puccini , Martin D. Berger , Madiha Naseem , Ryuma Tokunaga
Biochimica et Biophysica Acta 1868 ( 2) 439 -448
33
2017
Genomic profiling associated with recurrence in patients with rectal cancer treated with chemoradiation.
Michael A Gordon , Ji Gil , Bo Lu , Wu Zhang
Pharmacogenomics 7 ( 1) 67 -88
49
2006
Serum lactate dehydrogenase levels and glycolysis significantly correlate with tumor VEGFA and VEGFR expression in metastatic CRC patients.
Mizutomo Azuma , Michael Shi , Kathleen D Danenberg , Humphrey Gardner
Pharmacogenomics 8 ( 12) 1705 -1713
49
2007
Potential role of PIN1 genotypes in predicting benefit from oxaliplatin-based and irinotecan-based treatment in patients with metastatic colorectal cancer.
Mitsukuni Suenaga , Marta Schirripa , Shu Cao , Wu Zhang
Pharmacogenomics Journal 18 ( 5) 623 -632
4
2018
A polymorphism in the cachexia-associated gene INHBA predicts efficacy of regorafenib in patients with refractory metastatic colorectal cancer
Yuji Miyamoto , Marta Schirripa , Mitsukuni Suenaga , Shu Cao
PLOS ONE 15 ( 9) 1 -17
4
2020
PD-0009 Primary Tumor Location is a Major Independent Prognostic Factor for Mcrc Patients
Fotios Loupakis , Dongyun Yang , Shibao Feng , Chiara Cremolini
Annals of Oncology 23
2012
PD-0016 KSR1 Gene Polymorphism in Mcrc Patients Treated with First-Line Folfiri and Bevacizumab
Marta Schirripa , Fotios Loupakis , Chiara Cremolini , Yang Dongyun
Annals of Oncology 23
2012
P-0263 Prospective Study of Egfr Intron 1 CA Tandem Repeats as Predictive Factor of Benefit from Cetuximab and Irinotecan
Carlotta Antoniotti , Fotios Loupakis , Chiara Cremolini , Wu Zhang
Annals of Oncology 23
2012
P-0262 Prospective Evaluation of Candidate Snps of Vegf/Vegfr Pathway in Metastatic Colorectal Cancer Patients Treated with First-Line Folfiri Plus Bevacizumab (BV)
Chiara Cremolini , Fotios Loupakis , Dongyun Yang , Lisa Salvatore
Annals of Oncology 23
2012
NDRG1 as a biomarker for metastasis, recurrence and of poor prognosis in hepatocellular carcinoma
Jun Cheng , Hai-Yang Xie , Xiao Xu , Jian Wu
Cancer Letters 310 ( 1) 35 -45
131
2011